LEMAITRE VASCULAR INC (LMAT) › Cost of RevenueLEMAITRE VASCULAR INC (LMAT) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $26.21M2017: $30.17M2018: $31.63M2019: $37.38M2020: $44.75M2021: $53.04M2022: $56.76M2023: $66.44M2024: $68.96M2025: $71.06M$71.06M2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$71.06M+3.0%2024$68.96M+3.8%2023$66.44M+17.1%2022$56.76M+7.0%2021$53.04M+18.5%2020$44.75M+19.7%2019$37.38M+18.2%2018$31.63M+4.8%2017$30.17M+15.1%2016$26.21M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share